CIK 0001894562 · <br>Emerging growth company
Prime Medicine, Inc.
Sign in to watch- Ticker
- PRME
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-465-0013
- Business address
- 60 FIRST ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-24 | GV 2019 GP, L.L.C. 10% owner | Conversion | +1,762,440 | 1,762,440 | ||
| 2022-10-24 | GV 2019 GP, L.L.C. 10% owner | Purchase | +800,000 | $17.00 | $13.6M | 11,522,248 |
| 2022-10-24 | GV 2019 GP, L.L.C. 10% owner | Conversion · Series A Convertible Preferred Stock | −33,333,331 | 0 | ||
| 2022-10-24 | GV 2019 GP, L.L.C. 10% owner | Conversion · Series B Convertible Preferred Stock | −5,479,076 | 0 | ||
| 2022-10-24 | ARCH Venture Partners X, LLC 10% owner | Conversion | +5,728,297 | 5,728,297 | ||
| 2022-10-24 | ARCH Venture Partners X, LLC 10% owner | Conversion | +5,728,297 | 5,728,297 | ||
| 2022-10-24 | ARCH Venture Partners X, LLC 10% owner | Purchase | +400,000 | $17.00 | $6.8M | 6,128,297 |
| 2022-10-24 | ARCH Venture Partners X, LLC 10% owner | Purchase | +400,000 | $17.00 | $6.8M | 6,128,297 |
| 2022-10-24 | ARCH Venture Partners X, LLC 10% owner | Conversion · Series A Convertible Preferred Stock | −16,666,667 | 0 | ||
| 2022-10-24 | ARCH Venture Partners X, LLC 10% owner | Conversion · Series A Convertible Preferred Stock | −16,666,664 | 0 | ||
| 2022-10-24 | ARCH Venture Partners X, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −1,141,474 | 0 | ||
| 2022-10-24 | ARCH Venture Partners X, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −1,141,474 | 0 | ||
| 2022-10-24 | NELSEN ROBERT Director | Conversion | +5,728,297 | 5,728,297 | ||
| 2022-10-24 | NELSEN ROBERT Director | Conversion | +5,728,297 | 5,728,297 | ||
| 2022-10-24 | NELSEN ROBERT Director | Purchase | +400,000 | $17.00 | $6.8M | 6,128,297 |
| 2022-10-24 | NELSEN ROBERT Director | Purchase | +400,000 | $17.00 | $6.8M | 6,128,297 |
| 2022-10-24 | NELSEN ROBERT Director | Conversion | +16,080 | 16,080 | ||
| 2022-10-24 | NELSEN ROBERT Director | Conversion · Series A Convertible Preferred Stock | −16,666,667 | 0 | ||
| 2022-10-24 | NELSEN ROBERT Director | Conversion · Series A Convertible Preferred Stock | −16,666,664 | 0 | ||
| 2022-10-24 | NELSEN ROBERT Director | Conversion · Series B Convertible Preferred Stock | −1,141,474 | 0 |
Page 11 of 13 · 241 trades